Herantis Pharma to Participate in the Upcoming Virtual Conference

On May 28, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will be holding a digital company presentation at the following virtual investor conference (Press release, Herantis Pharma, MAY 28, 2021, View Source,c3355594 [SID1234583257]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event Details: Redeye Investor Forum Online

Date: 2 June 2021

Presentation Time: 10:50 CEST / 11:50 EEST

The presentation will be available via a digital library, which is accessible to event participants only. Here you will find the registration link to register for the broadcast: View Source